Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Head Office Relocation,Research Facility Expansion

19 Jul 2013 07:00

RNS Number : 6779J
Plant Health Care PLC
19 July 2013
 



19 July 2013

 

PLANT HEALTH CARE PLC

 

Plant Health Care relocates head office and expands research facilities

 

Plant Health Care (AIM/CISX: PHC.L), a leading provider of naturally derived products to the agriculture industry, announces that it is relocating its headquarters from Pittsburgh, PA to Raleigh, NC. The relocation will take place during the remainder of 2013, with completion of the transition by the end of this year. 

 

The company is also significantly increasing its research activities and personnel. The research facilities have now moved from their previous location to a much-expanded office and laboratory facility in the Seattle, WA area. The new facilities are approximately four times the size of the previous location and will accommodate additional senior scientists and technicians.

 

Dr. Christopher Richards, Chairman of Plant Health Care commented on the head office relocation: "The Board and Shareholders of Plant Health Care concluded that relocating the headquarters of the company to one of the major global agriculture industry communities was in the best interests of the company. North Carolina is home to a number of leading agriculture players and offers world-class infrastructure, workforce and resources for our business."

 

Paul Schmidt, CEO of Plant Health Care commented on the research expansion: "Our recent successful placing enables us to ramp-up our research activities significantly over the next few years. The primary focus of this enhanced effort will be the continued discovery and development of the Harpin technology platform, driven by the current commercial success of Harpin alpha-beta and by very promising early results with third generation products."

 

Dr. Zhongmin Wei, Vice President and Chief Science Officer of Plant Health Care commented: "The expansion of the research investment and activities is an exciting development for Plant Health Care. We have developed a remarkable platform of technology and intellectual property and the opportunity to continue expanding and accelerating this development is extremely exciting. I have been involved in the development of Plant Health Care's technology for a long time and am thrilled with the opportunity to take this platform to the next level."

 

- ENDS-

 

About Plant Health Care, plc: Plant Health Care, plc ("PHC") is a leading provider of naturally derived products for plants and soil. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") in February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at agriculture industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management.

 

Further information is available at: www.planthealthcare.com or please contact:

 

 

Plant Health Care plc
 
Paul Schmidt, Chief Executive Officer
Tel: +1-412-826-5488
Stephen Weaver, Finance Director
Tel: +1-412-826-5488
 
 
Nomura Code Securities
 Tel: +44 (0) 20 7776 1200
Clare Terlouw / Chris Golden
 
 
 
Powerscourt
Tel: +44 (0) 20 7250 1446
Paul Durman / Nick Dibden / Sophie Moate
 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGMGMNGRVGFZZ
Date   Source Headline
29th Aug 200810:37 amRNSNotice of Results
15th Aug 200812:36 pmRNSHolding(s) in Company
1st Aug 20081:08 pmRNSTotal Voting Rights
7th Jul 200812:21 pmRNSHolding(s) in Company
4th Jul 20087:00 amRNSProduct Update
3rd Jul 20087:00 amRNSCleantech Index
2nd Jul 200812:07 pmRNSStock Award
1st Jul 200811:49 amRNSTotal Voting Rights
17th Jun 20085:36 pmRNSAdditional Listing
17th Jun 20083:47 pmRNSNotification of Shareholding
13th Jun 20082:07 pmRNSHolding(s) in Company
12th Jun 20087:00 amRNSField Trials
6th Jun 200812:59 pmRNSResult of Annual General Meet
6th Jun 20087:00 amRNSAGM Statement and Trading Upd
3rd Jun 20087:30 amRNSField Trials
2nd Jun 20089:50 amRNSTotal Voting Rights
13th May 200812:41 pmRNSDirectors' dealings and addit
1st May 20082:39 pmRNSAdditional Listing
30th Apr 20086:11 pmRNSAnnual Report and Accounts
30th Apr 200811:24 amRNSTotal Voting Rights
28th Apr 20088:09 amRNSNew Trials
14th Apr 20085:39 pmRNSDirector/PDMR Shareholding
2nd Apr 20086:18 pmRNSDirector/PDMR Shareholding
1st Apr 20087:01 amRNSTotal Voting Rights
1st Apr 20087:01 amRNSDirectorate Change
31st Mar 20087:02 amRNSFinal Results
12th Mar 20084:40 pmRNSAdditional Listing
29th Feb 20084:59 pmRNSTotal Voting Rights
21st Feb 20087:01 amRNSStatement re Monsanto
18th Feb 20088:00 amRNSASA Partnership
12th Feb 20085:14 pmRNSAdditional Listing
31st Jan 20084:03 pmRNSTotal Voting Rights
21st Jan 20087:01 amRNSRe Agreement
21st Jan 20087:01 amRNSProduct Update
21st Jan 20087:01 amRNSTrading Statement
14th Jan 200811:57 amRNSNotification of Shareholding
9th Jan 20089:00 amRNSField Trial Update
31st Dec 200712:51 pmRNSTotal Voting Rights
19th Dec 20079:00 amRNSNotification of Shareholding
3rd Dec 20073:00 pmRNSTotal Voting Rights
20th Nov 20079:15 amRNSAdditional Listing
1st Nov 200712:16 pmRNSTotal Voting Rights
24th Oct 20076:13 pmRNSStock Award
22nd Oct 200710:35 amRNSNotification of Shareholding
5th Oct 20073:56 pmRNSNotification of Shareholding
2nd Oct 20074:46 pmRNSNotification of Shareholding
2nd Oct 200712:59 pmRNSTotal Voting Rights
1st Oct 20075:54 pmRNSNotification of Shareholding
1st Oct 20075:51 pmRNSNotification of Shareholding
1st Oct 20073:22 pmRNSDoc re. Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.